Recorded fact · drug.label_indication
drug.label_indication for aripiprazole-lauroxil|schizophrenia
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 0ebebf77 resolves to.
The record
| Fact id | 0ebebf77f362379958d92bb1 |
|---|---|
| Entity | drug: aripiprazole-lauroxil|schizophrenia |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20250128 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
ARISTADA is indicated for the treatment of schizophrenia in adults [see Clinical Studies ( 14 )].
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 937e7509b9e9bcdd652946c8cac23fb8a29613aab12420b83e1de53777b9c625.
The value
{
"ingredient": "Aripiprazole Lauroxil",
"conditionId": "schizophrenia",
"conditionName": "Schizophrenia",
"matchedAlias": "schizophrenia",
"context": "indication",
"brand": "ARISTADA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "17a8d11b-73b0-4833-a0b4-cf1ef85edefb",
"labelEffectiveTime": "20250128",
"labelsRead": 2,
"labelsNaming": 2,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 98e5f426b463a8f540efd3bb376336af89c79acc0f52690c52b0f2f8c38ae128.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.